![Carole Faig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carole Faig
Director/Board Member at
HENRY SCHEIN, INC.
Net worth: 614 555 $ as of 2026-05-30
Profile
Carole T.
Faig currently works at Henry Schein, Inc., as Independent Director from 2023, QuVa Pharma, Inc., as Director, Affinia Therapeutics, Inc., as Independent Director from 2021, Program for Appropriate Technology in Health, as Director from 2022, and The Scan Group, Inc., as Director from 2025.
Ms. Faig also formerly worked at Cue Health, Inc., as Independent Director from 2021 to 2024 and Ernst & Young LLP, as Partner from 1997 to 2020.
Ms. Faig received her undergraduate degree from Sam Houston State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HENRY SCHEIN, INC. 0.01% | 2026-03-22 | 8,025 ( 0.01% ) | 614 555 $ | 2026-05-30 |
Carole Faig active positions
| Companies | Position | Start |
|---|---|---|
| HENRY SCHEIN, INC. | Director/Board Member | 2023-12-17 |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Director/Board Member | 2021-08-31 |
QuVa Pharma, Inc.
 QuVa Pharma, Inc. Medical SpecialtiesHealth Technology Manufactures sterile injectable products | Director/Board Member | - |
Program for Appropriate Technology in Health
 Program for Appropriate Technology in Health Miscellaneous Commercial ServicesCommercial Services Provides social healthcare services | Director/Board Member | 2022-11-30 |
The Scan Group, Inc.
 The Scan Group, Inc. Advertising/Marketing ServicesCommercial Services Provides advertising, digital marketing, graphic design and printing services | Director/Board Member | 2025-01-31 |
Former positions of Carole Faig
| Companies | Position | End |
|---|---|---|
| CUE HEALTH INC. | Director/Board Member | 2024-05-23 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 2019-12-31 |
Training of Carole Faig
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
99
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Henry Schein, Inc.
 Henry Schein, Inc. Medical DistributorsDistribution Services Distributes healthcare products and services | Distribution Services |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Sam Houston State University
 Sam Houston State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Program for Appropriate Technology in Health
Program for Appropriate Technology in Health Miscellaneous Commercial ServicesCommercial Services Provides social healthcare services | Commercial Services |
The Scan Group, Inc.
The Scan Group, Inc. Advertising/Marketing ServicesCommercial Services Provides advertising, digital marketing, graphic design and printing services | Commercial Services |
Cue Health, Inc.
 Cue Health, Inc. Medical SpecialtiesHealth Technology Develops a wireless diagnostic device that enables consumers to run clinical lab tests at home to measure their own health | Health Technology |
QuVa Pharma, Inc.
QuVa Pharma, Inc. Medical SpecialtiesHealth Technology Manufactures sterile injectable products | Health Technology |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
- Stock Market
- Insiders
- Carole Faig
